The Medicines Company to Announce First Quarter 2019 Financial Results on April 25

18 Apr 2019

The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, April 25, 2019 at 8:30 a.m. EDT to discuss its first quarter 2019 financial results and operational developments.

The conference call may be accessed by telephone as follows:

U.S./Canada: (877) 407-0312

International: (201) 389-0899

Conference ID: 13689751

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

U.S./Canada: (877) 660-6853

International: (201) 612-7415

Conference ID: 13689751

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. An archived webcast will be available after the call concludes.

About The Medicines Company

The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. Our team is focused on transformational solutions that address the daily challenges that patients, physicians and payers confront in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit and follow us on Twitter @MDCONews and LinkedIn.

Dial in for $MDCO #Q12019 financial results and operational developments on Thu, Apr 25. Conference call & audio webcast to begin at 8:30 AM EDT.

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information